Search

Your search keyword '"Bernasconi, Paolo"' showing total 581 results
Start Over Author "Bernasconi, Paolo"
581 results on '"Bernasconi, Paolo"'

1. Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial

Author

Cavallaro, Gianluca, Grassi, Anna, Pavoni, Chiara, Micò, Maria Caterina, Busca, Alessandro, Cavattoni, Irene Maria, Santarone, Stella, Borghero, Carlo, Olivieri, Attilio, Milone, Giuseppe, Chiusolo, Patrizia, Musto, Pellegrino, Saccardi, Riccardo, Patriarca, Francesca, Pane, Fabrizio, Saporiti, Giorgia, Rivela, Paolo, Terruzzi, Elisabetta, Cerretti, Raffaella, Marotta, Giuseppe, Carella, Angelo Michele, Nagler, Arnon, Russo, Domenico, Corradini, Paolo, Bernasconi, Paolo, Iori, Anna Paola, Castagna, Luca, Mordini, Nicola, Oldani, Elena, Di Grazia, Carmen, Bacigalupo, Andrea, and Rambaldi, Alessandro

Published
2024
Full Text
View/download PDF

2. Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trial

Author

Raiola, Anna Maria, Bruno, Benedetto, Risitano, Antonio Maria, Mosna, Federico, Cavattoni, Irene Maria, Onida, Francesco, Saporiti, Giorgia, Patriarca, Francesca, Battista, Marta Lisa, Pavone, Vincenzo, Mele, Anna, Chiusolo, Patrizia, Sica, Simona, Loteta, Barbara, di Grazia, Carmen, Carella, Angelo Michele, Salvatore, Dalila, Morello, Enrico, Leoni, Alessandro, Giaccone, Luisa, Bernasconi, Paolo, Terruzzi, Elisabetta, Mordini, Nicola, Borghero, Carlo, Zallio, Francesco, Luppi, Mario, Grassi, Anna, Olivieri, Attilio, Piras, Eugenia, Sacchi, Nicoletta, Ciccone, Giovannino, Castiglione, Anna, Degrandi, Eliana, Angelucci, Emanuele, Martino, Massimo, and Bonifazi, Francesca

Published
2025
Full Text
View/download PDF

3. Novel Drug Combinations and Donor Lymphocyte Infusions Allow Prolonged Disease Control in Multiple Myeloma Patients Relapsing after Allogeneic Transplantation

Author

Nozzoli, Chiara, Pucillo, Martina, Giaccone, Luisa, Rambaldi, Alessandro, Stanghellini, Maria Teresa Lupo, Benedetti, Edoardo, Russo, Domenico, Mordini, Nicola, Mangiacavalli, Silvia, Bernasconi, Paolo, Parma, Matteo, Carluccio, Paola, Galieni, Piero, Rivela, Paolo, Martino, Massimo, Chiusolo, Patrizia, Isola, Miriam, De Martino, Maria, Oldani, Elena, Degrandi, Eliana, Boncompagni, Riccardo, Antonioli, Elisabetta, Carnevale, Fabrizio, Tozzi, Monica, Selleri, Carmine, Fanin, Renato, and Patriarca, Francesca

Published
2025
Full Text
View/download PDF

5. Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01

Author

Bonifazi, Francesca, Pavoni, Chiara, Peccatori, Jacopo, Giglio, Fabio, Arpinati, Mario, Busca, Alessandro, Bernasconi, Paolo, Grassi, Anna, Iori, Anna Paola, Patriarca, Francesca, Brunello, Lucia, Di Grazia, Carmen, Carella, Angelo Michele, Cilloni, Daniela, Picardi, Alessandra, Proia, Anna, Santarone, Stella, Sorasio, Roberto, Carluccio, Paola, Chiusolo, Patrizia, Cupri, Alessandra, Luppi, Mario, Nozzoli, Chiara, Baronciani, Donatella, Casini, Marco, Grillo, Giovanni, Musso, Maurizio, Onida, Francesco, Palazzo, Giulia, Parma, Matteo, Tringali, Stefania, Vacca, Adriana, Vallisa, Daniele, Sacchi, Nicoletta, Oldani, Elena, Masciulli, Arianna, Gheorghiu, Angela, Girmenia, Corrado, Martino, Massimo, Bruno, Benedetto, Rambaldi, Alessandro, and Ciceri, Fabio

Published
2022
Full Text
View/download PDF

6. Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT

Author

Swoboda, Ryszard, Labopin, Myriam, Giebel, Sebastian, Angelucci, Emanuele, Arat, Mutlu, Aljurf, Mahmoud, Sica, Simona, Pavlu, Jiri, Socié, Gerard, Bernasconi, Paolo, Rigacci, Luigi, Tischer, Johanna, Risitano, Antonio, Rovira, Montserrat, Saccardi, Riccardo, Pioltelli, Pietro, Van Gorkom, Gwendolyn, Vitek, Antonin, Savani, Bipin N., Spyridonidis, Alexandros, Peric, Zinaida, Nagler, Arnon, and Mohty, Mohamad

Published
2022
Full Text
View/download PDF

7. Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT

Author

Kröger, Nicolaus, Sbianchi, Giulia, Sirait, Tiarlan, Wolschke, Christine, Beelen, Dietrich, Passweg, Jakob, Robin, Marie, Vrhovac, Radovan, Helbig, Grzegorz, Sockel, Katja, Conneally, Eibhlin, Rubio, Marie Thérèse, Beguin, Yves, Finke, Jürgen, Bernasconi, Paolo, Morozova, Elena, Clausen, Johannes, von dem Borne, Peter, Schaap, Nicolaas, Schroyens, Wilfried, Patriarca, Francesca, Di Renzo, Nicola, Yeğin, Zeynep Arzu, Hayden, Patrick, McLornan, Donal, and Yakoub-Agha, Ibrahim

Published
2021
Full Text
View/download PDF

8. Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study

Author

Malagola, Michele, Polverelli, Nicola, Martino, Massimo, Patriarca, Francesca, Bruno, Benedetto, Giaccone, Luisa, Grillo, Giovanni, Bramanti, Stefania, Bernasconi, Paolo, De Gobbi, Marco, Natale, Annalisa, Terruzzi, Elisabetta, Olivieri, Attilio, Chiusolo, Patrizia, Carella, Angelo Michele, Casini, Marco, Maffini, Enrico, Nozzoli, Chiara, Mazza, Patrizio, Bassi, Simona, Onida, Francesco, Vacca, Adriana, Falcioni, Sadia, Luppi, Mario, Iori, Anna Paola, Pavone, Vincenzo, Skert, Cristina, Carluccio, Paola, Borghero, Carlo, Proia, Anna, Selleri, Carmine, Rubini, Vicky, Sacchi, Nicoletta, Oldani, Elena, Bonifazi, Francesca, Ciceri, Fabio, Russo, Domenico, Bernardi, Simona, Farina, Mirko, Fiore, Maria, Lupo Stanghellini, Maria Teresa, Fanin, Renato, Faraci, Danilo Giuseppe, Castagna, Luca, Colombo, Anna Amelia, Nicoli, Paolo, Santarone, Stella, Scortechini, Ilaria, Metafuni, Elisabetta, Merla, Emanuela, Cavattoni, Irene, Cutini, Ilaria, Mazzone, Annamaria, Saporiti, Giorgia, Canale, Filippo Antonio, Piras, Eugenia, Galieni, Piero, Debbia, Giulia, Rocca, Ursula La, Mele, Anna, Carobolante, Francesca, Elice, Francesca, and Fanelli, Fulvia

Published
2023
Full Text
View/download PDF

10. Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for T Cell Acute Lymphoblastic Leukemia: A Report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party

Author

Bazarbachi, Ali, Labopin, Myriam, Angelucci, Emanuele, Gülbas, Zafer, Ozdogu, Hakan, Arat, Mutlu, de Rosa, Luca, Pastano, Rocco, Pioltelli, Pietro, Montserrat, Rovira, Martino, Massimo, Ciceri, Fabio, Koç, Yener, Socié, Gerard, Blaise, Didier, Herrera, Concepcion, Chalandon, Yves, Bernasconi, Paolo, Marotta, Giuseppe, Castagna, Luca, McDonald, Andrew, Visani, Guiseppe, Carluccio, Paola, Vitek, Antonin, Simand, Célestine, Afanasyev, Boris, Rösler, Wolf, Diez-Martin, J.L., Nagler, Arnon, Brissot, Eolia, Giebel, Sebastian, and Mohty, Mohamad

Published
2020
Full Text
View/download PDF

11. Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party

Author

Bazarbachi, Abdul Hamid, Al Hamed, Rama, Labopin, Myriam, Halaburda, Kazimierz, Labussiere, Helene, Bernasconi, Paolo, Schroyens, Wilfried, Gandemer, Virginie, Schaap, Nicolaas P. M., Loschi, Michael, Jindra, Pavel, Snowden, John, Wu, Depei, Guffroy, Blandine, Rovira, Montserrat, Chantepie, Sylvain P., Poiré, Xavier, Lopez-Corral, Lucia, Nikolousis, Manos, Pelosini, Matteo, Ciceri, Fabio, Baron, Frederic, Bazarbachi, Ali, Corbacioglu, Selim, Savani, Bipin N., Peric, Zinaida, Nagler, Arnon, Carreras, Enric, and Mohty, Mohamad

Published
2021
Full Text
View/download PDF

12. Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia

Author

Nagler, Arnon, Dholaria, Bhagirathbhai, Labopin, Myriam, Savani, Bipin N., Angelucci, Emanuele, Koc, Yener, Arat, Mutlu, Pioltelli, Pietro, Sica, Simona, Gülbas, Zafer, Tischer, Johanna, Bernasconi, Paolo, Pavlu, Jiri, Socié, Gerard, Blaise, Didier, Rigacci, Luigi, Martino, Massimo, Diez-Martin, Jose Luis, Perić, Zinaida, Giebel, Sebastian, and Mohty, Mohamad

Published
2020
Full Text
View/download PDF

14. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO)

Author

Candoni, Anna, Rambaldi, Alessandro, Fanin, Renato, Velardi, Andrea, Arcese, William, Ciceri, Fabio, Lazzarotto, Davide, Lussana, Federico, Olivieri, Jacopo, Grillo, Giovanni, Parma, Matteo, Bruno, Benedetto, Sora, Federica, Bernasconi, Paolo, Saccardi, Riccardo, Foà, Robin, Sessa, Mariarosa, Bresciani, Paola, Giglio, Fabio, Picardi, Alessandra, Busca, Alessandro, Sica, Simona, Perruccio, Katia, Zucchetti, Elisa, Diral, Elisa, Iori, Anna Paola, Colombo, Anna Amelia, Tringali, Stefano, Santarone, Stella, Irrera, Giuseppe, Mancini, Stefano, Zallio, Francesco, Malagola, Michele, Albano, Francesco, Carella, Angelo Michele, Olivieri, Attilio, Tecchio, Cristina, Dominietto, Alida, Vacca, Adriana, Sorasio, Roberto, Orciuolo, Enrico, Risitano, Antonio Maria, Leotta, Salvatore, Cortelezzi, Agostino, Mammoliti, Sonia, Oldani, Elena, and Bonifazi, Francesca

Published
2019
Full Text
View/download PDF

16. GITMO Registry Study on Allogeneic Transplantation in Patients Aged ≥60 Years from 2000 to 2017: Improvements and Criticisms

Author

Malagola, Michele, Polverelli, Nicola, Rubini, Vicky, Martino, Massimo, Patriarca, Francesca, Bruno, Benedetto, Giaccone, Luisa, Grillo, Giovanni, Bramanti, Stefania, Bernasconi, Paolo, De Gobbi, Marco, Natale, Annalisa, Terruzzi, Elisabetta, Olivieri, Attilio, Chiusolo, Patrizia, Carella, Angelo Michele, Casini, Marco, Nozzoli, Chiara, Mazza, Patrizio, Bassi, Simona, Onida, Francesco, Vacca, Adriana, Falcioni, Sadia, Luppi, Mario, Iori, Anna Paola, Pavone, Vincenzo, Skert, Cristina, Carluccio, Paola, Borghero, Carlo, Proia, Anna, Selleri, Carmine, Sacchi, Nicoletta, Mammoliti, Sonia, Oldani, Elena, Ciceri, Fabio, Russo, Domenico, and Bonifazi, Francesca

Published
2022
Full Text
View/download PDF

17. Donor Cell Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: A Case Report and Literature Review

Author

Micheloni, Giovanni, primary, Frattini, Annalisa, additional, Donini, Marta, additional, Dusi, Stefano, additional, Leszl, Anna, additional, Di Meglio, Annamaria, additional, Pigazzi, Martina, additional, Musio, Antonio, additional, Zecca, Marco, additional, Mina, Tommaso, additional, Rabusin, Marco, additional, Roccia, Pamela, additional, Bernasconi, Paolo, additional, Dambruoso, Irene, additional, Minelli, Antonella, additional, Montalbano, Giuseppe, additional, Acquati, Francesco, additional, Porta, Giovanni, additional, Valli, Roberto, additional, and Pasquali, Francesco, additional

Published
2023
Full Text
View/download PDF

18. Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei Trapianti

Author

Picardi, Alessandra, Sacchi, Nicoletta, Miotti, Valeria, Lorentino, Francesca, Oldani, Elena, Rambaldi, Alessandro, Sessa, Mariarosaria, Bruno, Benedetto, Cerno, Michela, Vago, Luca, Bernasconi, Paolo, Arcese, William, Benedetti, Fabio, Pioltelli, Pietro, Russo, Domenico, Farina, Lucia, Fagioli, Franca, Guidi, Stefano, Saporiti, Giorgia, Zallio, Francesco, Chiusolo, Patrizia, Borghero, Carlo, Papalinetti, Gabriele, La Rocca, Ursula, Milone, Giuseppe, Lamparelli, Teresa, Carella, Angelo M., Luppi, Mario, Olivieri, Attilio, Martino, Massimo, Carluccio, Paola, Celeghini, Ivana, Andreani, Marco, Gallina, Anna M., Patriarca, Francesca, Pollichieni, Simona, Mammoliti, Sonia, Miccichè, Silvia, Mangione, Ilaria, Ciceri, Fabio, and Bonifazi, Francesca

Published
2021
Full Text
View/download PDF

19. Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation

Author

Ruggeri, Annalisa, de Wreede, Liesbeth C., Müller, Carlheinz R., Crivello, Pietro, Bonneville, Edouard F., Petersdorf, Effie W., Socié, Gerard, Dubois, Valérie, Niittyvuopio, Riitta, Peräsaari, Juha, Yakoub-Agha, Ibrahim, Cornelissen, Jan J., Wieten, Lotte, Gedde-Dahl, Tobias, Forcade, Edouard, Crawley, Charles R., Marsh, Steven G.E., Gandemer, Virginie, Tholouli, Eleni, Bulabois, Claude-Eric, Huynh, Anne, Choi, Goda, Deconinck, Eric, Itäla-Remes, Maija, Lenhoff, Stig, Bengtsson, Mats, Johansson, Jan-Erik, van Gorkom, Gwendolyn, Hoogenboom, Jorinde D., Vago, Luca, Rocha, Vanderson, Bonini, Chiara, Chabannon, Christian, Fleischhauer, Katharina, Clausen, Johannes, Holter, Wolfgang, Kalhs, Peter, Beguin, Yves, Bron, Dominique, Deeren, Dries, Lung, Wu Ka, Kerre, Tessa, Poiré, Xavier, Selleslag, Dominik, Schroyens, Wilfried, Jindra, Pavel, Mayer, Jiri, Vydra, Jan, Zák, Pavel, Nielsen, Bendt, Sengeloev, Henrik, Kaare, Ain, Partanen, Anu, Bay, Jacques-Olivier, Bertrand, Yves, Blaise, Didier, Bourhis, Jean Henri, Chevallier, Patrice, Cluzeau, Thomas, Damaj, Gandhi, Fegueux, Nathalie, Guyotat, Denis, Hunault-Berger, Mathilde, Labussière-Wallet, Hélène, Leleu, Xavier, Lioure, Bruno, Maury, Sebastien, Michel, Gérard, Mohty, Mohamad, Rubio, Marie Thérèse, Tilly, Herve, Turlure, Pascal, Bethge, Wolfgang, Casper, Jochen, Einsele, Hermann, Ganser, Arnold, Kröger, Nicolaus, Martin, Sonja, Platzbecker, Uwe, Reinhardt, Christian, Schäfer-Eckart, Kerstin, Thurner, Lorenz, Valerius, Thomas, Wulf, Gerald G., Karakasis, Dimitrios, Spyridonidis, Alexandros, Hauser, Peter, Reményi, Péter, Reykdal, Sigrun, Mousavi, Ashrafsadat, Angelucci, Emanuele, Arcese, William, Benedetti, Fabio, Bernasconi, Paolo, Biondi, Andrea, Bonifazi, Francesca, Carella, Angelo Michele, Carluccio, Paola, Casini, Marco, Cavanna, Luigi, Ciceri, Fabio, Cimino, Giuseppe, Corradini, Paolo, Fanin, Renato, Galieni, Piero, Grillo, Giovanni, Iori, Anna Paola, La Nasa, Giorgio, Locatelli, Franco, Marotta, Giuseppe, Martino, Massimo, Mazza, Patrizio, Mordini, Nicola, Musso, Maurizio, Olivieri, Attilio, Pavone, Vincenzo, Pane, Fabrizio, Petrini, Mario, Pioltelli, Pietro, Rambaldi, Alessandro, Ruggeri, Marco, Saccardi, Riccardo, Santarone, Stella, Scimè, Rosanna, Sica, Simona, Tarella, Corrado, Velardi, Andrea, Visani, Giuseppe, Zecca, Marco, Tanase, Alina, Kulagin, Aleksandr, Savchenko, Valery, López, Carmen Albo, Amor, Adrián Alegre, López, Jose Luis Bello, Caballero, Dolores, Duarte, Rafael, Cascon, Maria Jesús Pascual, Porras, Rocio Parody, Pérez-Simón, Jose Antonio, Rovira, Montserrat, Sanz, Jaime, Carrete, Juan Pio Torres, Cammenga, Jörg, Isaksson, Cecilia, Mielke, Stephan, Chalandon, Yves, Passweg, Jakob, Schanz, Urs, Meijer, Ellen, Kuball, Jürgen, Veelken, Joan Hendrik, Apperley, Jane, Bloor, Adrian, Byrne, Jenny, Carpenter, Ben, Clark, Andrew, Collin, Matthew, Craddock, Charles, Gibson, Brenda E., Khan, Anjum, Martin, Murray, Medd, Patrick, Nicholson, Emma, Orchard, Kim, Patel, Amit, Peniket, Andy, Potter, Victoria, Snowden, John, Wilson, Keith M.O., RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Transplant. Immunology/Tissue Typing lab, Interne Geneeskunde, MUMC+: MA Hematologie (9), Hematology, IRCCS San Raffaele Scientific Institute [Milan, Italie], EFS, CHU Lille, Erasmus University Medical Center [Rotterdam] (Erasmus MC), Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht], Oslo University Hospital [Oslo], CHU Bordeaux [Bordeaux], CHU Pontchaillou [Rennes], Institut de Génétique et Développement de Rennes (IGDR), Université de Rennes (UR)-Centre National de la Recherche Scientifique (CNRS)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), University of Groningen [Groningen], Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), and Essen University Hospital

Subjects
Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA, [SDV]Life Sciences [q-bio], HSCT, Medizin, Hematology, Hematologi
Abstract

International audience; Not available.

Published
2023
Full Text
View/download PDF

20. Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R

Author

Della Porta, Matteo G., Alessandrino, Emilio Paolo, Bacigalupo, Andrea, van Lint, Maria Teresa, Malcovati, Luca, Pascutto, Cristiana, Falda, Michele, Bernardi, Massimo, Onida, Francesco, Guidi, Stefano, Iori, Anna Paola, Cerretti, Raffaella, Marenco, Paola, Pioltelli, Pietro, Angelucci, Emanuele, Oneto, Rosi, Ripamonti, Francesco, Bernasconi, Paolo, Bosi, Alberto, Cazzola, Mario, and Rambaldi, Alessandro

Published
2014
Full Text
View/download PDF

21. Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT

Author

Kröger, Nicolaus, Sbianchi, Giulia, Sirait, Tiarlan, Wolschke, Christine, Beelen, Dietrich, Passweg, Jakob, Robin, Marie, Vrhovac, Radovan, Helbig, Grzegorz, Sockel, Katja, Conneally, Eibhlin, Rubio, Marie Thérèse, Beguin, Yves, Finke, Jürgen, Bernasconi, Paolo, Morozova, Elena, Clausen, Johannes, von dem Borne, Peter, Schaap, Nicolaas, Schroyens, Wilfried, Patriarca, Francesca, Di Renzo, Nicola, Yeğin, Zeynep Arzu, Hayden, Patrick, McLornan, Donal, and Yakoub-Agha, Ibrahim

Abstract

JAK1/2 inhibitor ruxolitinib (RUX) is approved in patients with myelofibrosis but the impact of pretreatment with RUX on outcome after allogeneic hematopoietic stem cell transplantation (HSCT) remains to be determined. We evaluated the impact of RUX on outcome in 551 myelofibrosis patients who received HSCT without (n= 274) or with (n= 277) RUX pretreatment. The overall leukocyte engraftment on day 45 was 92% and significantly higher in RUX responsive patients than those who had no or lost response to RUX (94% vs. 85%, p= 0.05). The 1-year non-relapse mortality was 22% without significant difference between the arms. In a multivariate analysis (MVA) RUX pretreated patients with ongoing spleen response at transplant had a significantly lower risk of relapse (8.1% vs. 19.1%; p= 0.04)] and better 2-year event-free survival (68.9% vs. 53.7%; p= 0.02) in comparison to patients without RUX pretreatment. For overall survival the only significant factors were age > 58 years (p= 0.03) and HLA mismatch donor (p= 0.001). RUX prior to HSCT did not negatively impact outcome after transplantation and patients with ongoing spleen response at time of transplantation had best outcome.

Published
2024
Full Text
View/download PDF

22. 1070 PROGNOSTIC PERFORMANCE OF CARDIAC MAGNETIC RESONANCE IMAGING MARKERS VERSUS COMPLICATED CLINICAL PRESENTATION AFTER AN ACUTE MYOCARDITIS

Author

Varrenti, Marisa, primary, Ammirati, Enrico, additional, Sormani, Paola, additional, Moro, Claudio, additional, D´elia, Saverio, additional, Bernasconi, Paolo, additional, Raineri, Claudia, additional, Quattrocchi, Giuseppina, additional, Milazzo, Angela, additional, Maestroni, Alberto, additional, Valsecchi, Maria Grazia, additional, Garascia, Andrea, additional, Oliva, Fabrizio, additional, Giannattasio, Cristina, additional, Camici, Paolo G, additional, and Pedrotti, Patrizia, additional

Published
2022
Full Text
View/download PDF

23. Long-Term Analysis of an Open-Label, Multicentre, Randomized Phase 3 Trial Comparing Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine As a Preparative Regimen for Allogeneic Stem-Cell Transplantation in Patients with Acute Myeloid Leukemia

Author

Cavallaro, Gianluca, primary, Grassi, Anna, additional, Pavoni, Chiara, additional, Mico', Maria Caterina, additional, Busca, Alessandro, additional, Cavattoni, Irene Maria, additional, Santarone, Stella, additional, Borghero, Carlo, additional, Olivieri, Attilio, additional, Milone, Giuseppe, additional, Chiusolo, Patrizia, additional, Musto, Pellegrino, additional, Saccardi, Riccardo, additional, Patriarca, Francesca, additional, Pane, Fabrizio, additional, Saporiti, Giorgia, additional, Rivela, Paolo, additional, Terruzzi, Elisabetta, additional, Cerretti, Raffaella, additional, Marotta, Giuseppe, additional, Carella, Angelo Michele, additional, Nagler, Arnon, additional, Russo, Domenico, additional, Corradini, Paolo, additional, Bernasconi, Paolo, additional, Iori, Anna Paola, additional, Castagna, Luca, additional, Mordini, Nicola, additional, Oldani, Elena, additional, Di Grazia, Carmen, additional, Bacigalupo, Andrea, additional, and Rambaldi, Alessandro, additional

Published
2022
Full Text
View/download PDF

24. Impact of Fourth Methotrexate Dose in ATG-Cyclosporine GvHD Prophylaxis in HLA-Matched Unrelated HSCT: A GITMO Study

Author

Picardi, Alessandra, primary, Lorentino, Francesca, additional, Rambaldi, Alessandro, additional, Bruno, Benedetto, additional, Benedetti, Fabio, additional, Cerno, Michela, additional, Bernasconi, Paolo, additional, Arcese, William, additional, Pioltelli, Pietro, additional, Russo, Domenico, additional, Bacigalupo, Andrea, additional, Martino, Massimo, additional, Angelucci, Emanuele, additional, Carella, Angelo Michele, additional, Onida, Francesco, additional, Olivieri, Attilio, additional, Raiola, Anna Maria, additional, Iori, Anna Paola, additional, Patriarca, Francesca, additional, Oldani, Elena, additional, Ciceri, Fabio, additional, and Bonifazi, Francesca, additional

Published
2022
Full Text
View/download PDF

25. Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis

Author

Luatti, Simona, Castagnetti, Fausto, Marzocchi, Giulia, Baldazzi, Carmen, Gugliotta, Gabriele, Iacobucci, Ilaria, Specchia, Giorgina, Zanatta, Lucia, Rege-Cambrin, Giovanna, Mancini, Marco, Abruzzese, Elisabetta, Zaccaria, Alfonso, Grimoldi, Maria Grazia, Gozzetti, Alessandro, Ameli, Gaia, Capucci, Maria Adele, Palka, Giandomenico, Bernasconi, Paolo, Palandri, Francesca, Pane, Fabrizio, Saglio, Giuseppe, Martinelli, Giovanni, Rosti, Gianantonio, Baccarani, Michele, and Testoni, Nicoletta

Published
2012
Full Text
View/download PDF

27. Total body irradiation + fludarabine compared to busulfan + fludarabine as 'reduced-toxicity conditioning' for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT

Author

Giebel, Sebastian, Labopin, Myriam, Sobczyk-Kruszelnicka, Malgorzata, Stelljes, Matthias, Byrne, Jenny, Fegueux, Nathalie, Beelen, Dietrich, Rovira, Montserrat, Spyridonidis, Alexandros, Blaise, Didier, Bornhäuser, Martin, Karadogan, Ihsan, Savani, Bipin, Nagler, Arnon, Mohty, Mohamad, Martin, Sonja, Chevallier, Patrice, Neubauer, Andreas, Damaj, Gandhi, Koc, Yener, Ganser, Arnold, Collin, Matthew, Yakoub-Agha, Ibrahim, Ozdogu, Hakan, Araujo, Mercedes Colorado, Itäla-Remes, Maija, Orchard, Kim, Isaksson, Cecilia, Bethge, Wolfgang, Martin, Hans, Aljurf, Mahmoud, Faber, Edgar, Caballero, Dolores, Zák, Pavel, Leleu, Xavier, Bay, Jacques-Olivier, Rohrlich, Pierre-Simon, Kröger, Nicolaus, Huynh, Anne, Schäfer-Eckart, Kerstin, Milpied, Noel, Lenhoff, Stig, Ho, Aloysius, López, Jose Luis Bello, Mordini, Nicola, Lioure, Bruno, Halaburda, Kazimierz, Olivieri, Attilio, Gedde-Dahl, Tobias, Protheroe, Rachel, Tischer, Johanna, Klammer, Matthias, Clausen, Johannes, Potter, Victoria, Ladetto, Marco, Tilly, Herve, Deconinck, Eric, Brecht, Arne, Müller, Lutz Peter, Heinicke, Thomas, Carrete, Juan Pio Torres, Bazarbachi, Ali, Reményi, Péter, Rubio, Marie Thérèse, Fanin, Renato, Pérez-Simón, Jose Antonio, Niels, Murawski, Diez-Martin, J., Arat, Mutlu, Hermine, Olivier, Socié, Gerard, Cornelissen, Jan, Santarone, Stella, Guyotat, Denis, Bulabois, Claude Eric, Bernasconi, Paolo, Johansson, Jan-Erik, Vrhovac, Radovan, Greinix, Hildegard, Lorenzo, José Luis López, Apte, Shashikant, Craddock, Charles, Kobbe, Guido, Zahrani, Mohsen Al, Dreger, Peter, Lange, Andrzej, Tbakhi, Abdelghani, Meijer, Ellen, Llamas, Carlos Vallejo, Santasusana, Josep Maria Ribera, Corradini, Paolo, Benedetti, Fabio, Rambaldi, Alessandro, Gandemer, Virginie, Malfuson, Jean-Valère, Kaare, Ain, Risitano, Antonio, Petrini, Mario, Selleri, Carmine, Wu, Depei, Hematology, CCA - Cancer Treatment and quality of life, Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, and Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

Subjects
medicine.medical_specialty, Transplantation Conditioning, MESH: Busulfan, Medizin, MESH: Graft vs Host Disease, Graft vs Host Disease, [SDV.CAN]Life Sciences [q-bio]/Cancer, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Busulfan, MESH: Hematopoietic Stem Cell Transplantation, MESH: Transplantation Conditioning, Retrospective Studies, Transplantation, Acute leukemia, MESH: Humans, MESH: Middle Aged, business.industry, Hazard ratio, Hematopoietic Stem Cell Transplantation, Myeloid leukemia, MESH: Retrospective Studies, Retrospective cohort study, Hematology, Middle Aged, Total body irradiation, Fludarabine, Leukemia, Myeloid, Acute, Regimen, 030220 oncology & carcinogenesis, MESH: Vidarabine, [SDV.IMM]Life Sciences [q-bio]/Immunology, MESH: Leukemia, Myeloid, Acute, business, MESH: Whole-Body Irradiation, Vidarabine, Whole-Body Irradiation, 030215 immunology, medicine.drug
Abstract

International audience; The optimal conditioning for patients with acute myeloid leukemia in first complete remission treated with allogeneic hematopoietic cell transplantation (allo-HCT) has not been defined so far. In this retrospective study, we compared two "reduced-toxicity" regimens: intravenous busulfan at a total dose of 9.6 mg/kg (3 days) + fludarabine (Bu3/Flu) and total body irradiation at a dose of 8 Gy + fludarabine (TBI8Gy/Flu). In the entire study cohort (n = 518), the probabilities of overall survival (OS), leukemia-free survival (LFS), relapse and non-relapse mortality (NRM) at 2 years for Bu3/Flu and TBI8Gy/Flu were 62% vs. 72.5% (p = 0.051), 59.5% vs. 65% (p = 0.15), 30% vs. 20% (p = 0.01), and 10% vs. 14% (p = 0.18), respectively. In multivariate model for patients

Published
2021
Full Text
View/download PDF

30. Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP

Author

Testoni, Nicoletta, Marzocchi, Giulia, Luatti, Simona, Amabile, Marilina, Baldazzi, Carmen, Stacchini, Monica, Nanni, Mauro, Rege-Cambrin, Giovanna, Giugliano, Emilia, Giussani, Ursula, Abruzzese, Elisabetta, Kerim, Simonetta, Grimoldi, Maria Grazia, Gozzetti, Alessandro, Crescenzi, Barbara, Carcassi, Carlo, Bernasconi, Paolo, Cuneo, Antonio, Albano, Francesco, Fugazza, Giuseppina, Zaccaria, Alfonso, Martinelli, Giovanni, Pane, Fabrizio, Rosti, Gianantonio, and Baccarani, Michele

Published
2009
Full Text
View/download PDF

32. Comprehensive characterization of mesenchymal stromal cells from patients with Fanconi anaemia

Author

Mantelli, Melissa, Avanzini, Maria Antonia, Rosti, Vittorio, Ingo, Daniela M., Conforti, Antonella, Novara, Francesca, Arrigo, Giulia, Boni, Marina, Zappatore, Rita, Lenta, Elisa, Moretta, Antonia, Acquafredda, Gloria, de Silvestri, Annalisa, Cirillo, Valentina, Cicchetti, Elisa, Algeri, Mattia, Strocchio, Luisa, Vinti, Luciana, Starc, Nadia, Biagini, Simone, Sirleto, Pietro, Bernasconi, Paolo, Zuffardi, Orsetta, Maserati, Emanuela, Maccario, Rita, Zecca, Marco, Locatelli, Franco, and Bernardo, Maria Ester

Published
2015
Full Text
View/download PDF

33. Bulletin 2/16 «Das Tessin und seine Beziehungen zur Schweiz und zu Europa»

Author

Zürcher, Markus, Kübli, Beatrice, Luigi Badilatti, Michele, Hafner, Albert, Budmiger, Luzia, Bertoli, Manuele, Christopher, Sabine, Moretti, Bruno, Martinoli, Piero, Gervasoni, Franco, Hengartner, Michael, Albertoni, Luca, Gaggini, Cristina, Bernasconi, Paolo, Lorenzetti, Luigi, Beltraminelli, Paolo, and Wirth, Katja

Subjects
Schweizerische Akademie der Geistes- und Sozialwissenschaften
Abstract

Das Tessin und seine Beziehungen zur Schweiz und zu Europa., Cite as: Zürcher, Markus et al. (2016): Bulletin 2/16 «Das Tessin und seine Beziehungen zur Schweiz und zu Europa».

Published
2021
Full Text
View/download PDF

35. Overall Survival Improvement Following ALLO-SCT in Patients Older THAN 60 YEARS: A Gruppo Italiano Trapianto DI Midollo Osseo (GITMO) Registry Study

Author

Malagola, Michele, primary, Polverelli, Nicola, additional, Martino, Massimo, additional, Rubini, Vicky, additional, Lupo Stanghellini, Maria Teresa, additional, Patriarca, Francesca, additional, Fanin, Renato, additional, Bruno, Benedetto, additional, Giaccone, Luisa, additional, Faraci, Danilo Giuseppe, additional, Grillo, Giovanni, additional, Bramanti, Stefania, additional, Castagna, Luca, additional, Bernasconi, Paolo, additional, Colombo, Anna Amelia, additional, De Gobbi, Marco, additional, Nicoli, Paolo, additional, Natale, Annalisa, additional, Santarone, Stella, additional, Terruzzi, Elisabetta, additional, Olivieri, Attilio, additional, Scortechini, Ilaria, additional, Chiusolo, Patrizia, additional, Metafuni, Elisabetta, additional, Carella, Angelo Michele, additional, Merla, Emanuela, additional, Casini, Marco, additional, Cavattoni, Irene M, additional, Arpinati, Mario, additional, Nozzoli, Chiara, additional, Cutini, Ilaria, additional, Mazza, Patrizio, additional, Mazzone, Annamaria, additional, Bassi, Simona, additional, Onida, Francesco, additional, Saporiti, Giorgia, additional, Canale, Filippo Antonio, additional, Vacca, Adriana, additional, Piras, Eugenia, additional, Galieni, Piero, additional, Falcioni, Sadia, additional, Luppi, Mario, additional, Debbia, Giulia, additional, Iori, Anna Paola, additional, La Rocca, Ursula, additional, Pavone, Vincenzo, additional, Mele, Anna, additional, Skert, Cristina, additional, Carobolante, Francesca, additional, Carluccio, Paola, additional, Borghero, Carlo, additional, Elice, Francesca, additional, Proia, Anna, additional, Fanelli, Fulvia, additional, Selleri, Carmine, additional, Sacchi, Nicoletta, additional, Mammoliti, Sonia, additional, Oldani, Elena, additional, Ciceri, Fabio, additional, Bonifazi, Francesca, additional, and Russo, Domenico, additional

Published
2021
Full Text
View/download PDF

36. Impact of Prior Jak-Inhibitor Therapy With Ruxolitinib on Outcome After Allogeneic Stem Cell Transplantation For Myelofibrosis. A Large EBMT-CMWP Study

Author

Kroeger, Nicolaus, Sbianchi, Giulia, Sirait, Tiarlan, Beelen, Dietrich, Passweg, Jakob, Robin, Marie, Vrhovac, Radovan, Helbig, Grzegor, Sockel, Katja, Conneally, Eibhlin, Rubio, Marie Therese, Beguin, Yves, Finke, Juergen, Bernasconi, Paolo, Morozova, Elena, Clausen, Johannes, Dem Borne, Peter, Nicolaas Schaap, Schroyens, Wilfried, Patriarca, Francesca, Di Renzo, Nicola, Yegin, Zeynep Arzu, Hayden, Patrick, Mclornan, Donal, and Yakoub-Agha, Ibrahim

Published
2021

38. Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma

Author

Arcaini, Luca, Morello, Lucia, Tucci, Alessandra, Rusconi, Chiara, Ladetto, Marco, Rattotti, Sara, Bonfichi, Maurizio, Bottelli, Chiara, Gabutti, Cristina, Bernasconi, Paolo, Varettoni, Marzia, Gotti, Manuel, Troletti, Daniela, Guerrera, Maria Luisa, Fiaccadori, Valeria, Sciarra, Roberta, Ferretti, Virginia Valeria, Alessandrino, Emilio Paolo, Rossi, Giuseppe, and Morra, Enrica

Published
2015
Full Text
View/download PDF

42. Progressive Multifocal Leukoencephalopathy (PML) after HCT - A Retrospective Study of Infectious Diseases working Party EBMT

Author

Dybko, Jaroslaw, Gil, Lidia, Wendel, Lotus, Knelange, Nina, Kroeger, Nicoalus, Hayat, Amjad, Liga, Maria, Blijlevens, Nicole, Bazarbachi, Ali, Faraci, Maura, Arnold, Ganser, Steinhardt, Maximilian, Gruhn, Bernd, Stamouli, Maria, Villar, Sara, Pass-weg, Jakob, Schots, Rik, Bernasconi, Paolo, Zucker-man, Tsila, Mikulska, Malgorzata, Styczynski, Jan, Faculty of Law and Criminology, Clinical sciences, and Hematology

Published
2020

43. Comparison of Dynamic International Prognostic Scoring System and MYelofibrosis SECondary to PV and ET Prognostic Model for Prediction of Outcome in Polycythemia Vera and Essential Thrombocythemia Myelofibrosis after Allogeneic Stem Cell Transplantation

Author

Gagelmann, Nico, Eikema, Diderik-Jan, de Wreede, Liesbeth C, Koster, Linda, Wolschke, Christine, Arnold, Renate, Kanz, Lothar, McQuaker, Grant, Marchand, Tony, Socié, Gerard, Bourhis, Jean Henri, Mohty, Mohamad, Cornelissen, Jan J, Chevallier, Patrice, Bernasconi, Paolo, Stelljes, Matthias, Rohrlich, Pierre-Simon, Fanin, Renato, Finke, Jürgen, Maertens, Johan, Blaise, Didier, Itälä-Remes, Maija, Labussière-Wallet, Hélène, Robin, Marie, McLornan, Donal, Chalandon, Yves, Yakoub-Agha, Ibrahim, Kröger, Nicolaus, CMWP of the European Society for Blood and Marrow Transplantation, Hematology, and Medical Oncology

Subjects
Adult, medicine.medical_specialty, Essential thrombocythemia, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Polycythemia vera, Internal medicine, Humans, Transplantation, Homologous, Medicine, Allogeneic stem cell transplantation, Secondary myelofibrosis, Hematology, Transplantation, Myelofibrosis, Polycythemia Vera, Survival analysis, Aged, ddc:616, Framingham Risk Score, business.industry, Hematopoietic Stem Cell Transplantation, Middle Aged, Prognosis, medicine.disease, Survival Analysis, Treatment Outcome, Primary Myelofibrosis, International Prognostic Scoring System, 030220 oncology & carcinogenesis, Cohort, business, Thrombocythemia, Essential, 030215 immunology
Abstract

We aimed to validate the MYelofibrosis SECondary to PV and ET prognostic model (MYSEC-PM) in 159 patients with myelofibrosis secondary to polycythemia vera (PV) and essential thrombocythemia (ET) from the European Society for Blood and Marrow Transplantation registry undergoing transplantation from matched siblings or unrelated donors. Furthermore, we aimed to test its prognostic performance in comparison with the Dynamic International Prognostic Scoring System (DIPSS). Score performance was analyzed using the concordance index (C): the probability that a patient who experienced an event had a higher risk score than a patient who did not (C > .5 suggesting predictive ability). Median follow-up of the total cohort was 41 months (range, 34 to 54), 45 months in post-PV and 38 months in post-ET myelofibrosis. Survival at 1, 2, and 4 years was 70% (95% CI, 63% to 77%), 61% (95% CI, 53% to 69%), and 52% (95% CI, 43% to 61%) for the total cohort; 70% (95% CI, 59% to 80%), 61% (95% CI, 49% to 73%), and 51% (95% CI, 38% to 64%) for post-PV; and 71% (95% CI, 61% to 81%), 61% (95% CI, 50% to 72%), and 54% (95% CI, 42% to 66%) for post-ET myelofibrosis (P = .78). Overall, the DIPSS was not significantly predictive of outcome (P = .28). With respect to the MYSEC-PM, overall survival at 4 years was 69% for the low-risk, 55% for the intermediate 1-risk, 47% for the intermediate 2-risk, and 22% (0% to 45%) for the high-risk groups. The prognostic model was predictive of survival overall (P = .05), whereas groups with intermediate 2 and high risk showed no significant difference (P = .44). Assessment of prognostic utility yielded a C-index of .575 (95% CI, .502 to .648) for the DIPSS, whereas assessment of the MYSEC-PM resulted in a C-statistics of .636 (95% CI, .563 to .708), indicating improvement in prediction of post-transplant survival using the new MYSEC-PM. In addition, transplantations from an unrelated donor in comparison with an HLA-identical sibling showed worse outcome (P = .04), and transplant recipients seropositive for cytomegalovirus in comparison with seronegative recipients (P = .01) showed worse survival. In conclusion, incorporating transplant-specific and clinical and mutational information together with the MYSEC-PM may enhance risk stratification. ispartof: Biol Blood Marrow Transplant vol:25 issue:6 pages:e204-e208 ispartof: location:United States status: published

Published
2019

44. Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party.

Author

UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Centre du cancer, UCL - (SLuc) Service d'hématologie, Bazarbachi, Abdul Hamid, Al Hamed, Rama, Labopin, Myriam, Halaburda, Kazimierz, Labussiere, Helene, Bernasconi, Paolo, Schroyens, Wilfried, Gandemer, Virginie, Schaap, Nicolaas P M, Loschi, Michael, Jindra, Pavel, Snowden, John, Wu, Depei, Guffroy, Blandine, Rovira, Montserrat, Chantepie, Sylvain P, Poiré, Xavier, Lopez-Corral, Lucia, Nikolousis, Manos, Pelosini, Matteo, Ciceri, Fabio, Baron, Frederic, Bazarbachi, Ali, Corbacioglu, Selim, Savani, Bipin N, Peric, Zinaida, Nagler, Arnon, Carreras, Enric, Mohty, Mohamad, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Centre du cancer, UCL - (SLuc) Service d'hématologie, Bazarbachi, Abdul Hamid, Al Hamed, Rama, Labopin, Myriam, Halaburda, Kazimierz, Labussiere, Helene, Bernasconi, Paolo, Schroyens, Wilfried, Gandemer, Virginie, Schaap, Nicolaas P M, Loschi, Michael, Jindra, Pavel, Snowden, John, Wu, Depei, Guffroy, Blandine, Rovira, Montserrat, Chantepie, Sylvain P, Poiré, Xavier, Lopez-Corral, Lucia, Nikolousis, Manos, Pelosini, Matteo, Ciceri, Fabio, Baron, Frederic, Bazarbachi, Ali, Corbacioglu, Selim, Savani, Bipin N, Peric, Zinaida, Nagler, Arnon, Carreras, Enric, and Mohty, Mohamad

Abstract

Allogeneic hematopoietic cell transplantation (alloHCT) is a complex, potentially fatal therapy featuring a myriad of complications. Triggering event(s) of such complications vary significantly, but often a so-called "multi-organ failure" (MOF) is reported as the leading cause of death. The identification of the exact trigger of MOF is critical towards early and disease-specific intervention to improve outcome. We examined data from 202 alloHCT patients reported to have died of MOF from the EBMT registry aiming to determine their exact cause of death focusing on veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) due to its life-threatening, often difficult to capture yet preventable nature. We identified a total of 70 patients (35%) for whom VOD/SOS could be considered as trigger for MOF and leading cause of death, among which 48 (69%) were previously undiagnosed. Multivariate analysis highlighted history of hepatic comorbidity or gentuzumab use and disease status beyond CR1 as the only significant factors predictive of VOD/SOS incidence (OR = 6.6; p = 0.001 and OR = 3.3; p = 0.004 respectively). VOD/SOS-related MOF was widely under-reported, accounting for 27% of deaths attributed to MOF of unknown origin without a previous VOD/SOS diagnosis. Our results suggest most missed cases developed late VOD/SOS beyond 21 days post-alloHCT, highlighting the importance of the newly revised EBMT criteria.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results